Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 4

Interventions

Cyclophosphamide 548pembrolizumab 384Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Has results × Multiparametric Magnetic Resonance Imaging × Clear all
NCT06128525 2025-11-28

Prostate Resection After Microwave Ablation (PRAMA)

University of Southern California

Phase NA Completed
1 enrolled 5 charts
Genitourinary

Prostatic Neoplasms

NCT02242773 2025-07-11

MAST

University of Miami

Phase NA Completed
208 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT03180398 2023-10-12

Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients

Henry Ford Health System

Phase NA Terminated
9 enrolled 4 charts
Genitourinary

Prostatic Neoplasms

NCT01858688 2023-05-03

A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer

Dana-Farber Cancer Institute

Phase NA Completed
101 enrolled 18 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡